CCM
IMGN

Cinctive Capital Management’s Immunogen Inc IMGN Stock Holding History

Cinctive Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-134,951
Closed -$1M – 689
2021
Q4 		$1M Buy
134,951
+34,951
+35% +$217K 0.04% 405
2021
Q3 		$567K Buy
+100,000
New +$578K 0.03% 444

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cinctive Capital Management's IMGN Position: Q1 2022 in Review

Cinctive Capital Management sold out of Immunogen Inc (IMGN) in Q1 2022, closing a stake of 134,951 shares — an estimated $1M sold.

Cinctive Capital Management first reported a position in IMGN in Q3 2021 and held it in 2 quarters. The position peaked at $1M in Q4 2021. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2022.

  • Cinctive Capital Management reported no remaining Immunogen Inc position as of Q1 2022 after selling out during the quarter.
  • Cinctive Capital Management sold 134,951 Immunogen Inc shares in Q1 2022, an estimated $1M.
  • Cinctive Capital Management first reported a position in Immunogen Inc in Q3 2021 and held it in 2 quarters.
  • Cinctive Capital Management's Immunogen Inc position peaked at $1M in Q4 2021.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2022.

Based on Cinctive Capital Management's 13F filing for Q1 2022, filed 16 May 2022.